Comprehensive therapy
-
The rationale for thromboprophylaxis is based on the high prevalence of venous thromboembolism (VTE). Use of effective methods of prophylaxis is more cost-effective and is safer than selective, intensive screening for VTE. These therapeutic options will be discussed.
-
Comprehensive therapy · Jan 2008
Historical ArticleA brief history of scientific geriatric cardiology.
Comprehensive therapists need awareness of the long period of neglect of the elderly cardiac patient, its improvement in the last third of a century, and a look to the future.
-
Comprehensive therapy · Jan 2007
Health-seeking behaviors and sexually transmitted diseases among adolescents attending an urban pediatric emergency department.
Adolescents are often seen in Emergency departments (ED) for urgent care. Rates of treatable sexually transmitted diseases (Neisseria gonorrhoeae and Chlamydia trachomatis) are highest in this age group. This study examines the prevalence of these sexually transmitted diseases (STDs) and the health seeking characteristics of adolescents presenting to an urban pediatric ED. ⋯ This study confirms a high prevalence of treatable STDs among adolescents in an urban ED setting and provides information on frequency of ED usage and health-seeking behaviors among adolescents.
-
Comprehensive therapy · Jan 2007
Case ReportsA man with tropical travel history, fever, and pulmonary infiltrates.
Acute Respiratory Distress Syndrome (ARDS) are one of the most serious complications of falciparum malaria. Pathogenesis of ARDS along with factors contributing towards the development and treatment of ARDS is discussed.
-
Randomized, double-blind, placebo-controlled studies and observational studies have demonstrated that statins reduce mortality and major cardiovascular events in high-risk persons with hypercholesterolemia. The Heart Protection Study showed that statins reduced mortality and major cardiovascular events in high-risk persons, regardless of the initial level of serum lipids, age, or gender. Lipid-lowering therapy reduces cardiovascular morbidity and mortality in high-risk persons, forming the basis for the updated National Cholesterol Education Program (NCEP) III guidelines.